Company Overview and News

ADX Energy secures US$2 million to drill for gas in Romania

ADX Energy Limited (ASX:ADX) has secured a US$2 million investment from Reabold Resources PLC (LON:RBD), for a 29% shareholding in UK based Danube Petroleum, an ADX subsidiary.

ADX Energy secures US$2 million to drill for gas in Romania

ADX Energy Limited (ASX:ADX) has secured a US$2 million investment from Reabold Resources PLC (LON:RBD), for a 29% shareholding in UK based Danube Petroleum, an ADX subsidiary.

ADX Energy Ltd gets ready to raise

The halt will remain in place until the opening of trade on Thursday 10th November 2016, or earlier if an announcement is made to the market.

ADX Energy on the path to commercialise Nilde Oil Field

About 300 million barrels of oil initially in place (OIIP) has now been estimated for the Nilde Field based on additional field data acquired by ADX. The revised estimates factors in all the available geological, drilling and production data, adding credibility to the potential value of the Nilde Oil Field re-development plan. ADX is currently reviewing development options along with facility providers of FPSO’s (floating, production, storage and offloading facilities) and MOPU’s (mobile offshore production units).

Appendix 3B - Placement


Change in substantial holding


Placement Raises $800,000


ADX Energy Ltd in ASX trading halt

ADX Energy Ltd (ASX:ADX) operates four oil and gas permits in North Africa and Europe, together with gold and base metal interests in Australia.

Appendix 5B March 2016


Trading Halt


Investor Presentation


Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...